Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure
We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either...
Gespeichert in:
Veröffentlicht in: | Journal of ocular pharmacology and therapeutics 1997-12, Vol.13 (6), p.497-505 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 505 |
---|---|
container_issue | 6 |
container_start_page | 497 |
container_title | Journal of ocular pharmacology and therapeutics |
container_volume | 13 |
creator | SAHA, S. L ZHAN, G TANG, L OPERE, C ROCHE, E. B CAMRAS, C. B OHIA, S. E ROCHE, V. F |
description | We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either an aromatic methoxy or phenolic substituent. These molecules, in hydrochloride salt form, were assayed in doses ranging from 0.1-1.5%. All products and vehicle were administered topically to one eye of normotensive rabbits and intraocular pressure was measured in both eyes for up to six hours. Four of the five compounds examined produced a significant and, in some cases, prolonged, ocular hypotensive response. Secondary and N-methylated tertiary amines were equally effective, as were compounds containing either the 10-methoxy group of free phenol. Studies are currently in progress to optimize potency and identify functional and molecular mechanisms of action. |
doi_str_mv | 10.1089/jop.1997.13.497 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79521221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79521221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-f218ad5301d7aa4ce699d13bca37ee7804242481268355541d57ce09277037f3</originalsourceid><addsrcrecordid>eNo9kE1P3DAQhi1UBJT2zAnJh4pbFo8dx3FvBfVLQu2FS0_W4ExYo2wc7GRh_329YoXmMCO9z4w0D2MXIFYgWnv9FKcVWGtWoFa1NUfsDLQ2lTFKfiizaEVlmladso85PwkBSjRwwk5srRrQ6oz9uwl-54fgeUcpbHEOW8o89nxNr7jedSniFNO0DiPxr_xP3NLA8ZHGOfN5jTMf4gslHsY5YfTLgIlPiXJeEn1ixz0OmT4f-jm7__H9_vZXdff35-_bb3eVVxLmqpfQYqeVgM4g1p4aaztQDx6VITKtqGWpFmT5QmtdQ6eNJ2GlMUKZXp2zq7ezU4rPC-XZbUL2NAw4UlyyM1ZLkBIKeP0G-hRzTtS7KYUNpp0D4fYuXXHp9i4dKFdclo3Lw-nlYUPdO3-QV_Ivhxyzx6FPOPqQ3zEJxXVTq_-p2Hz5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79521221</pqid></control><display><type>article</type><title>Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>SAHA, S. L ; ZHAN, G ; TANG, L ; OPERE, C ; ROCHE, E. B ; CAMRAS, C. B ; OHIA, S. E ; ROCHE, V. F</creator><creatorcontrib>SAHA, S. L ; ZHAN, G ; TANG, L ; OPERE, C ; ROCHE, E. B ; CAMRAS, C. B ; OHIA, S. E ; ROCHE, V. F</creatorcontrib><description>We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either an aromatic methoxy or phenolic substituent. These molecules, in hydrochloride salt form, were assayed in doses ranging from 0.1-1.5%. All products and vehicle were administered topically to one eye of normotensive rabbits and intraocular pressure was measured in both eyes for up to six hours. Four of the five compounds examined produced a significant and, in some cases, prolonged, ocular hypotensive response. Secondary and N-methylated tertiary amines were equally effective, as were compounds containing either the 10-methoxy group of free phenol. Studies are currently in progress to optimize potency and identify functional and molecular mechanisms of action.</description><identifier>ISSN: 1080-7683</identifier><identifier>EISSN: 1557-7732</identifier><identifier>DOI: 10.1089/jop.1997.13.497</identifier><identifier>PMID: 9436153</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Animals ; Aporphines - chemical synthesis ; Aporphines - pharmacology ; Biological and medical sciences ; Bridged Bicyclo Compounds - chemical synthesis ; Bridged Bicyclo Compounds - pharmacology ; Eye ; Eye - drug effects ; Female ; Intraocular Pressure - drug effects ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Rabbits</subject><ispartof>Journal of ocular pharmacology and therapeutics, 1997-12, Vol.13 (6), p.497-505</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-f218ad5301d7aa4ce699d13bca37ee7804242481268355541d57ce09277037f3</citedby><cites>FETCH-LOGICAL-c321t-f218ad5301d7aa4ce699d13bca37ee7804242481268355541d57ce09277037f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3042,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2106164$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9436153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SAHA, S. L</creatorcontrib><creatorcontrib>ZHAN, G</creatorcontrib><creatorcontrib>TANG, L</creatorcontrib><creatorcontrib>OPERE, C</creatorcontrib><creatorcontrib>ROCHE, E. B</creatorcontrib><creatorcontrib>CAMRAS, C. B</creatorcontrib><creatorcontrib>OHIA, S. E</creatorcontrib><creatorcontrib>ROCHE, V. F</creatorcontrib><title>Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure</title><title>Journal of ocular pharmacology and therapeutics</title><addtitle>J Ocul Pharmacol Ther</addtitle><description>We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either an aromatic methoxy or phenolic substituent. These molecules, in hydrochloride salt form, were assayed in doses ranging from 0.1-1.5%. All products and vehicle were administered topically to one eye of normotensive rabbits and intraocular pressure was measured in both eyes for up to six hours. Four of the five compounds examined produced a significant and, in some cases, prolonged, ocular hypotensive response. Secondary and N-methylated tertiary amines were equally effective, as were compounds containing either the 10-methoxy group of free phenol. Studies are currently in progress to optimize potency and identify functional and molecular mechanisms of action.</description><subject>Animals</subject><subject>Aporphines - chemical synthesis</subject><subject>Aporphines - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Bridged Bicyclo Compounds - chemical synthesis</subject><subject>Bridged Bicyclo Compounds - pharmacology</subject><subject>Eye</subject><subject>Eye - drug effects</subject><subject>Female</subject><subject>Intraocular Pressure - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Rabbits</subject><issn>1080-7683</issn><issn>1557-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1P3DAQhi1UBJT2zAnJh4pbFo8dx3FvBfVLQu2FS0_W4ExYo2wc7GRh_329YoXmMCO9z4w0D2MXIFYgWnv9FKcVWGtWoFa1NUfsDLQ2lTFKfiizaEVlmladso85PwkBSjRwwk5srRrQ6oz9uwl-54fgeUcpbHEOW8o89nxNr7jedSniFNO0DiPxr_xP3NLA8ZHGOfN5jTMf4gslHsY5YfTLgIlPiXJeEn1ixz0OmT4f-jm7__H9_vZXdff35-_bb3eVVxLmqpfQYqeVgM4g1p4aaztQDx6VITKtqGWpFmT5QmtdQ6eNJ2GlMUKZXp2zq7ezU4rPC-XZbUL2NAw4UlyyM1ZLkBIKeP0G-hRzTtS7KYUNpp0D4fYuXXHp9i4dKFdclo3Lw-nlYUPdO3-QV_Ivhxyzx6FPOPqQ3zEJxXVTq_-p2Hz5</recordid><startdate>19971201</startdate><enddate>19971201</enddate><creator>SAHA, S. L</creator><creator>ZHAN, G</creator><creator>TANG, L</creator><creator>OPERE, C</creator><creator>ROCHE, E. B</creator><creator>CAMRAS, C. B</creator><creator>OHIA, S. E</creator><creator>ROCHE, V. F</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19971201</creationdate><title>Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure</title><author>SAHA, S. L ; ZHAN, G ; TANG, L ; OPERE, C ; ROCHE, E. B ; CAMRAS, C. B ; OHIA, S. E ; ROCHE, V. F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-f218ad5301d7aa4ce699d13bca37ee7804242481268355541d57ce09277037f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Aporphines - chemical synthesis</topic><topic>Aporphines - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Bridged Bicyclo Compounds - chemical synthesis</topic><topic>Bridged Bicyclo Compounds - pharmacology</topic><topic>Eye</topic><topic>Eye - drug effects</topic><topic>Female</topic><topic>Intraocular Pressure - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Rabbits</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SAHA, S. L</creatorcontrib><creatorcontrib>ZHAN, G</creatorcontrib><creatorcontrib>TANG, L</creatorcontrib><creatorcontrib>OPERE, C</creatorcontrib><creatorcontrib>ROCHE, E. B</creatorcontrib><creatorcontrib>CAMRAS, C. B</creatorcontrib><creatorcontrib>OHIA, S. E</creatorcontrib><creatorcontrib>ROCHE, V. F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of ocular pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SAHA, S. L</au><au>ZHAN, G</au><au>TANG, L</au><au>OPERE, C</au><au>ROCHE, E. B</au><au>CAMRAS, C. B</au><au>OHIA, S. E</au><au>ROCHE, V. F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure</atitle><jtitle>Journal of ocular pharmacology and therapeutics</jtitle><addtitle>J Ocul Pharmacol Ther</addtitle><date>1997-12-01</date><risdate>1997</risdate><volume>13</volume><issue>6</issue><spage>497</spage><epage>505</epage><pages>497-505</pages><issn>1080-7683</issn><eissn>1557-7732</eissn><abstract>We have synthesized a number of novel bicyclic hexahydroaporphines containing a phenethylamine moiety for preliminary study as intraocular pressure lowering agents. The target molecules were synthesized in a twelve step process. The final products were secondary or tertiary amines containing either an aromatic methoxy or phenolic substituent. These molecules, in hydrochloride salt form, were assayed in doses ranging from 0.1-1.5%. All products and vehicle were administered topically to one eye of normotensive rabbits and intraocular pressure was measured in both eyes for up to six hours. Four of the five compounds examined produced a significant and, in some cases, prolonged, ocular hypotensive response. Secondary and N-methylated tertiary amines were equally effective, as were compounds containing either the 10-methoxy group of free phenol. Studies are currently in progress to optimize potency and identify functional and molecular mechanisms of action.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>9436153</pmid><doi>10.1089/jop.1997.13.497</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1080-7683 |
ispartof | Journal of ocular pharmacology and therapeutics, 1997-12, Vol.13 (6), p.497-505 |
issn | 1080-7683 1557-7732 |
language | eng |
recordid | cdi_proquest_miscellaneous_79521221 |
source | Mary Ann Liebert Online Subscription; MEDLINE |
subjects | Animals Aporphines - chemical synthesis Aporphines - pharmacology Biological and medical sciences Bridged Bicyclo Compounds - chemical synthesis Bridged Bicyclo Compounds - pharmacology Eye Eye - drug effects Female Intraocular Pressure - drug effects Male Medical sciences Pharmacology. Drug treatments Rabbits |
title | Bicyclic derivatives of hexahydroaporphine : Novel agents that lower intraocular pressure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A24%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bicyclic%20derivatives%20of%20hexahydroaporphine%20:%20Novel%20agents%20that%20lower%20intraocular%20pressure&rft.jtitle=Journal%20of%20ocular%20pharmacology%20and%20therapeutics&rft.au=SAHA,%20S.%20L&rft.date=1997-12-01&rft.volume=13&rft.issue=6&rft.spage=497&rft.epage=505&rft.pages=497-505&rft.issn=1080-7683&rft.eissn=1557-7732&rft_id=info:doi/10.1089/jop.1997.13.497&rft_dat=%3Cproquest_cross%3E79521221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79521221&rft_id=info:pmid/9436153&rfr_iscdi=true |